Komori
StemCell Institute (7096) · RiskRestated

Impact of COVID-19 on Sales Channels and Business Performance

First written in FY2021. 6 of 9 entries say "Restated". Latest entry: FY2024-Q3.

9entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2022-Q1 – FY2023-Q1MitigatedFY2023-Q3 – FY2023RestatedFY2024-Q1 – FY2024-Q32021: 320212022: 220222023: 320232024: 12024
Same theme, other companies
Stagnation of Sales Activities and Business Negotiations Due to COVID-19A theme 58 companies write about · 58 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2020: 25 of 50 companies on the "Worse" side.

20 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 58 companies compared. The sentences above are computed from all 58.
Full recordFilings, disclosures and news, newest first
  1. FY2024-Q3RestatedAnnual report

    「In-person marketing, including talks and public relations activities at medical institutions, including obstetric facilities, our main marketing channel, which had been restricted during the COVID-19 pandemic, recovered significantly」

    The recovery of the main sales channels restricted by COVID-19 continues. The company states that there have been no new business or other risks and no material changes to existing risks.
  2. FY2024-Q1RestatedAnnual report

    「During the cumulative first quarter period, the WHO declared the end of the public health emergency relating to COVID-19, which had continued to have a significant impact on social and economic activity for 3 years, and its legal classification in Japan was changed from 8 May. As a result, medical institutions, including obstetric facilities, our main marketing channel, also accelerated their move toward normalization, including the normalization of medical care systems.」

    The company explains that, while recognizing the impact of COVID-19 on sales channels, the end of the WHO public health emergency and the change in its legal classification in Japan accelerated the normalization of obstetric facilities.
  3. FY2023MitigatedAnnual report

    「Regarding COVID-19, which had a significant impact on social and economic activity for 3 years, the WHO declared the end of the public health emergency, and its legal classification in Japan was changed from 8 May. As a result, medical institutions, our main marketing channel, were also accelerating their move toward normalization.」

    Although the impact of COVID-19 on sales channels continued for 3 years, the change in its legal classification and the normalization of medical institutions indicated that the impact was expected to decline.
  4. FY2023-Q3MitigatedAnnual report

    「Regarding COVID-19, which had a significant impact on social and economic activity for 3 years, the legal classification was scheduled to be reviewed in May, and medical institutions, our main marketing channel, were also moving toward normalization.」

    Although the impact of COVID-19 continued for the past 3 years, the legal classification review was approved and medical institutions were moving toward normalization, indicating that the impact on sales channels was expected to decline.
  5. FY2023-Q1RestatedAnnual report

    「The impact of COVID-19 on social and economic activity continued during the cumulative first quarter period, as well.」

    The impact of COVID-19 on social and economic activity continues to exist. Digital marketing and the umbilical cord storage service contributed to record-high quarterly net sales.
  6. FY2022RestatedAnnual report

    「Following the cancellation or voluntary suspension of mothers' classes, we have worked with facilities to distribute brochures and introduce our services and raise awareness of them. In addition to establishing new channels for introducing our services and raising awareness through the internet, including online advertising, we have established new initiatives at obstetric facilities.」

    Although the cancellation or voluntary suspension of mothers' classes continues, alternative channels have been established, including brochure distribution, online advertising, birth plans at obstetric facilities and digital signage.
  7. FY2022-Q2RestatedAnnual report

    「During the cumulative second quarter period, the impact of COVID-19 on social and economic activity continued.」

    The impact of COVID-19 on social and economic activity continues. The company is strengthening its digital marketing and facility operating systems, but states that no new risks have arisen and no material changes have occurred to existing risks.
  8. FY2022-Q1RestatedAnnual report

    「The spread of COVID-19 continued to have a significant impact on social and economic activity.」

    The impact of COVID-19 on social and economic activity continues to be described.
  9. FY2021MaterialisedAnnual report

    「As COVID-19 spread, many facilities continued to cancel or voluntarily suspend mothers' classes from February 2020 onward.」

    The cancellation or voluntary suspension of mothers' classes, the main sales channel, actually occurred. The company responded through online advertising, brochures, new initiatives at obstetric facilities and a two-team staffing system.
Moved together

"Launch of Umbilical Cord Tissue Storage Service" moved the same way as this thread, in the same document, in 2 of its 9 moves.

222★123
  1. ★This thread
  2. 1Launch of Umbilical Cord Tissue Storage Service2×
  3. 2Support for Clinical Research in Regenerative Medicine and Cell Therapy Using Umbilical Cord Blood2×
  4. 3Record-high sales and growth in operating profit2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for StemCell Institute yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.